2.Next-generation diagnostic pathology.
Xiu Wu BIAN ; Pei Pei ZHANG ; Yi Fang PING ; Xiao Hong YAO
Chinese Journal of Pathology 2022;51(1):3-6
With the technological progresses and applications of human genome sequencing, bioinformatics analysis and data mining, and molecular pathology and artificial intelligence-assisted pathological diagnosis, the development of clinical medicine is moving towards the era of precision diagnosis and treatment. In the context of this era, the traditional diagnostic pathology is facing unprecedented opportunities and challenges in our history and is striving towards the "next-generation diagnostic pathology" (NGDP). NGDP is based on histomorphology and clinical data, and characterized by the combination of molecular detection and bioinformatics analysis, intelligent sampling and process quality control, intelligent diagnosis and remote consultation, lesion visualization and "non-invasive" pathology as well as other innovative cutting edge interdisciplinary technologies. The NGDP reports will include the results from multi-omics and cross-scale integrated diagnosis for final diagnosis. NGDP will also be applied for predicting disease progression and outcomes, and determining optional therapeutics as well as assessing treatment responses, so that a novel "golden standard" of disease diagnosis can be established. In the near fature, it is necessary to stimulate the innovative vitality of pathology disciplines, accelerate the maturity and application for NGDP, update the theory and technical system of pathology, and perform its important applicable role in the prevention, diagnosis, treatment of diseases so that the futher development of clinical medicine will be promoted and the strategy for maintenance of being healthy in China will be served.
Artificial Intelligence
;
China
;
Computational Biology
;
Humans
;
Pathology, Molecular
3.Serum 25-hydroxyvitamin D inversely associated with blood eosinophils in patients with persistent allergic rhinitis
Hai Yan WU ; Jin Xiang CHEN ; Hui Qin TIAN ; Xiu Ling ZHANG ; Hai Yan BIAN ; Lei CHENG
Asia Pacific Allergy 2017;7(4):213-220
OBJECTIVE: The relationship between vitamin D and allergic rhinitis (AR) remains unclear. The present study investigated their association by examining serum 25-hydroxyvitamin D (25(OH)D) levels, blood eosinophils, and the expression of vitamin D receptors (VDR) on nasal mucosa in patients with AR. METHODS: A total of 32 patients with persistent AR and 25 controls were enrolled in this study. Serum 25(OH)D levels were detected by enzyme-linked immunosorbent assay, and eosinophils in the peripheral blood were examined by an automated hematology system, while VDR expression on inferior turbinate mucosa was assessed by immunohistochemistry. Furthermore, the correlation of serum 25(OH)D levels with blood eosinophils in persistent AR was analyzed. RESULTS: No significant difference in serum 25(OH)D levels was detected between the AR and control groups (p = 0.371). Interestingly, the serum 25(OH)D levels of the AR group were negatively correlated with blood eosinophil count and its proportion (p = 0.019 and p = 0.010, respectively) even when adjusting confounding factors including age, sex, body mass index, and the season of blood sampling. On the other hand, no significant difference in the expression levels of VDR on nasal mucosa was found between the AR group and the control group (p = 0.231). CONCLUSION: These results suggest that the serum 25(OH)D might be inversely associated with blood eosinophils in patients with persistent AR. However, the relationship between vitamin D and AR still requires further clarification
Body Mass Index
;
Enzyme-Linked Immunosorbent Assay
;
Eosinophils
;
Hand
;
Hematology
;
Humans
;
Immunohistochemistry
;
Mucous Membrane
;
Nasal Mucosa
;
Receptors, Calcitriol
;
Rhinitis, Allergic
;
Seasons
;
Turbinates
;
Vitamin D
4.Resistance to apoptosis should not be taken as a hallmark of cancer.
Rui-An WANG ; Zeng-Shan LI ; Qing-Guo YAN ; Xiu-Wu BIAN ; Yan-Qing DING ; Xiang DU ; Bao-Cun SUN ; Yun-Tian SUN ; Xiang-Hong ZHANG
Chinese Journal of Cancer 2014;33(2):47-50
In the research community, resistance to apoptosis is often considered a hallmark of cancer. However, pathologists who diagnose cancer via microscope often see the opposite. Indeed, increased apoptosis and mitosis are usually observed simultaneously in cancerous lesions. Studies have shown that increased apoptosis is associated with cancer aggressiveness and poor clinical outcome. Furthermore, overexpression of Bcl-2, an antiapoptotic protein, is linked with better survival of cancer patients. Conversely, Bax, CD95, Caspase-3, and other apoptosis-inducing proteins have been found to promote carcinogenesis. This notion of the role of apoptosis in cancer is not new; cancer cells were found to be short-lived 88 years ago. Given these observations, resistance to apoptosis should not be considered a hallmark of cancer.
Animals
;
Apoptosis
;
physiology
;
Biomarkers, Tumor
;
metabolism
;
Carcinogenesis
;
metabolism
;
Caspase 3
;
metabolism
;
Humans
;
Lymphoma, B-Cell
;
metabolism
;
pathology
;
Neoplasms
;
metabolism
;
pathology
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
;
Treatment Outcome
;
bcl-2-Associated X Protein
;
metabolism
;
fas Receptor
;
metabolism
5.Extending the CONSORT Statement to moxibustion.
Chung-wah CHENG ; Shu-fei FU ; Qing-hui ZHOU ; Tai-xiang WU ; Hong-cai SHANG ; Xu-dong TANG ; Zhi-shun LIU ; Jia LIU ; Zhi-xiu LIN ; Lixing LAO ; Ai-ping LÜ ; Bo-li ZHANG ; Bao-yan LIU ; Zhao-xiang BIAN
Journal of Integrative Medicine 2013;11(1):54-63
The STandards for Reporting Interventions in Clinical Trials Of Moxibustion (STRICTOM), in the form of a checklist and descriptions of checklist items, were designed to improve reporting of moxibustion trials, and thereby facilitating their interpretation and replication. The STRICTOM checklist included 7 items and 16 sub-items. These set out reporting guidelines for the moxibustion rationale, details of moxibustion, treatment regimen, other components of treatment, treatment provider background, control and comparator interventions, and precaution measures. In addition, there were descriptions of each item and examples of good reporting. It is intended that the STRICTOM can be used in conjunction with the main CONSORT Statement, extensions for nonpharmacologic treatment and pragmatic trials, and thereby raise the quality of reporting of clinical trials of moxibustion. Further comments will be solicited from the experts of the CONSORT Group, the STRICTA Group, acupuncture and moxibustion societies, and clinical trial authors for optimizing the STRICTOM.
Clinical Trials as Topic
;
methods
;
standards
;
Humans
;
Moxibustion
;
methods
;
standards
;
Randomized Controlled Trials as Topic
;
Research Design
;
standards
6.Tumor associated stem/progenitor cells in tumorigenesis and progression of cancer.
Chinese Journal of Pathology 2011;40(3):145-146
Animals
;
Cell Proliferation
;
Disease Progression
;
Endothelial Cells
;
pathology
;
Humans
;
Indoleamine-Pyrrole 2,3,-Dioxygenase
;
metabolism
;
Mesenchymal Stromal Cells
;
immunology
;
metabolism
;
pathology
;
Neoplasms
;
immunology
;
pathology
;
Neoplastic Stem Cells
;
pathology
;
Neovascularization, Pathologic
;
pathology
;
Stem Cells
;
pathology
;
T-Lymphocytes
;
immunology
;
pathology
7.Contribution of cancer stem cells to tumor vasculogenic mimicry.
Xiao-hong YAO ; Yi-fang PING ; Xiu-wu BIAN
Protein & Cell 2011;2(4):266-272
Vasculogenic mimicry (VM), a newly-defined pattern of tumor blood supply, provides a special passage without endothelial cells and is conspicuously different from angiogenesis and vasculogenesis. The biological features of the tumor cells that form VM remain unknown. Cancer stem cells (CSCs) are believed to be tumor-initiating cells, capable of self-renewal and multipotent differentiation, which resemble normal stem cells in phenotype and function. Recently CSCs have been shown to contribute to VM formation as well as angiogenesis. These findings challenge the previous understanding of the cellular basis of VM formation. In this review, we present evidence for participation of CSCs in VM formation. We also discuss the potential mechanisms and possible interaction of CSCs with various elements in tumor microenvironment niche. Based on the importance of VM in tumor progression, it constitutes a novel therapeutic target for cancer.
Animals
;
Cell Differentiation
;
Endothelial Cells
;
pathology
;
Epithelial-Mesenchymal Transition
;
Extracellular Matrix
;
metabolism
;
pathology
;
Humans
;
Mice
;
Molecular Mimicry
;
Neoplasms
;
blood supply
;
pathology
;
Neoplastic Processes
;
Neoplastic Stem Cells
;
pathology
;
Neovascularization, Pathologic
;
genetics
;
metabolism
;
Tumor Microenvironment
8.The biological features and their roles of cancer stem cells in invasion and neovascularization of cancer.
Chinese Journal of Pathology 2009;38(8):505-506
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Differentiation
;
Cell Proliferation
;
Connexin 43
;
metabolism
;
Humans
;
Neoplasm Invasiveness
;
pathology
;
physiopathology
;
Neoplasms
;
metabolism
;
pathology
;
physiopathology
;
Neoplastic Stem Cells
;
metabolism
;
pathology
;
physiology
;
Neovascularization, Pathologic
;
metabolism
;
pathology
;
physiopathology
;
Receptors, CXCR4
;
metabolism
;
Receptors, Formyl Peptide
;
metabolism
;
Vascular Endothelial Growth Factor A
;
metabolism
9.Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor.
Hua-Rong ZHANG ; Cheng-Ping XU ; Fei-Lan CHEN ; Xiu-Wu BIAN
Acta Pharmaceutica Sinica 2008;43(2):133-137
This study is to investigate whether the synthesized chiral compound Nordy has influence on the function of endothelial progenitor cells (EPCs) from human umbilical cord blood induced by vascular endothelial growth factor (VEGF). EPCs were isolated from human umbilical cord blood by density gradient centrifugation. After cultured for 7 -10 days, EPCs were prepared for detecting effect of Nordy on proliferation, migration and tubule-forming activity in Matrigel induced by VEGF. Incubation of EPCs with 100 micromol L(-1) Nordy for 24 h initially inhibited the proliferative capacity of EPCs induced by VEGF (P <0.05). Moreover, 25 -50 micromol L(-1) Nordy also exhibited inhibitory effect at 48 -72 h. In addition, 25 - 100 micromol L(-1) Nordy impaired EPCs migratory and tubule-forming capacity in vitro (P < 0.05). Nordy could inhibit in EPCs the functions of proliferation, migration and tubulogenesis induced by VEGF in vitro, which might be a possible mechanism of its anti-EPCs effects.
Antineoplastic Agents
;
pharmacology
;
Cell Movement
;
drug effects
;
Cell Proliferation
;
drug effects
;
Cells, Cultured
;
Endothelial Cells
;
cytology
;
Fetal Blood
;
cytology
;
Humans
;
Masoprocol
;
analogs & derivatives
;
pharmacology
;
Neovascularization, Physiologic
;
drug effects
;
Stem Cells
;
cytology
;
Vascular Endothelial Growth Factor A
;
antagonists & inhibitors
10.Protective effects of enalaprilat on the myocardial kinetics in rats at early stage of severe scald.
Bing-qian ZHANG ; Guang WANG ; Dong-xia ZHANG ; Yong-ming DANG ; Jiong-yu HU ; Hua-pei SONG ; Jia-ping ZHANG ; Xiu-wu BIAN ; Yue-sheng HUANG
Chinese Journal of Burns 2008;24(3):183-186
OBJECTIVETo investigate the therapeutic effects of Enalaprilat on the myocardial kinetics in rats at early stage of severe scald.
METHODSEighty-four SD rats were inflicted with 30% TBSA full-thickness scald, and randomly divided into scald (S, with intraperitoneal injection of isotonic saline according to Parkland formula, n=30), L (n=30), M (n=12) and H (n=12) groups. The rats in L,M,H groups were intraperitoneally injected with 1,2,4 mg/kg Enalaprilat. Other 6 healthy rats were enrolled into study as control (C group). The myocardial kinetic parameters including left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEDP), +/- dp/dt max and the levels of A II in myocardium were observed at 1,3,6,12 and 24 post scald hour (PBH) in L and S groups,and at 6,12 PBH in M and H groups. The above indices in C group were also examined.
RESULTSThe levels of LVSP, LVEDP, +/- dp/dt max in C group were higher than those in other groups during 3-24 PBH (P < 0.05 or P < 0.01), while those in L,M,H groups were obviously higher than those in S group (P < 0.05 or P < 0.01). The level of +/- dp/dt max in H group at 6,12 PBH were obviously lower than those in L and M groups. The level of A II in S group at 1 PBH was (53.0 +/- 2.6) pg/200 mg, which was significantly higher than thatin C group [(14.8 +/- 0.7) pg/200 mg, P < 0.05 or P < 0.01]; it peaked at6 PBH and lowered afterwards, and they were significantly higher than that in C group at 24 PBH (P < 0.01). The levels of A II in L group during 3-24 PBH were obviously higher than those in C group (P < 0.01), which were also lower than those in S group. The level of A II in S group was significantly higher than in L,M,H groups at 6 PBH [(145.2 +/- 14.5) pg/200 mg. vs. (65.1 +/- 0.9) pg/200 mg, (53.6 +/- 1.1) pg/200 mg, (34.2 +/- 0.9) pg/200 mg, respectively, P < 0.01].
CONCLUSIONMyocardium can be obviously damaged at early stage after severe scald,cardiac function is impaired. Enalaprilat injection (especially at low dose) can significantly ameliorate the myocardial kinetics indices, and it seems to exert a protective effect on cardiac function.
Animals ; Burns ; drug therapy ; physiopathology ; Dose-Response Relationship, Drug ; Enalaprilat ; pharmacology ; therapeutic use ; Myocardium ; pathology ; Rats ; Rats, Sprague-Dawley ; Ventricular Remodeling

Result Analysis
Print
Save
E-mail